Utrecht University: Clinical Trials

5 trials sponsored by Utrecht University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 3, Terminated 2

Follow Utrecht University: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin
Genotype-guided dosing algorithm, Standard care - Venous Thromboembolism, Atrial Fibrillation
Phase 4CompletedUtrecht Institute for Pharmaceutical Sciences4552011-01-012014-12-03
EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon
Genotype-guided dosing algorithm, Non-genotype-guided dosing algorithm - Venous Thromboembolism (VTE), Atrial Fibrillation (AF)
Phase 4CompletedUtrecht Institute for Pharmaceutical Sciences9702010-11-012013-06-18
EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol
Genotype-guided dosing algorithm, Non-genotype-guided dosing algorithm - Venous Thromboembolism, Atrial Fibrillation
Phase 4CompletedUtrecht Institute for Pharmaceutical Sciences9702010-11-012013-06-18
Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and Cognition
gabapentin - Chronic Neuropathic Pain
Phase 4TerminatedUMC Utrecht242003-04-012005-09-16
Effects of Amitriptyline for the Treatment of Pain on Driving Performance and Cognition.
amitriptyline - Chronic Neuropathic Pain
Phase 4TerminatedUMC Utrecht242002-10-012005-09-16

Conditions studied

Atrial Fibrillation (3)  ·  Venous Thromboembolism (3)  ·  Neuralgia (2)

Interventions

Amitriptyline (1)  ·  Gabapentin (1)  ·  Standard of Care (1)

Countries

Netherlands (4)  ·  Austria (1)  ·  Germany (1)  ·  Greece (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Edmund Volkerts, PhD (2)  ·  Munir Pirmohamed, MD PhD (1)

Results publications

PMID 24251360, PMID 28063245, PMID 24251363

NIH funding

2009 (2)